Status:
COMPLETED
Evaluation of the Safety and Efficacy of Vardenafil in Subjects With Erectile Dysfunction
Lead Sponsor:
Bayer
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
Erectile Dysfunction
Eligibility:
MALE
18+ years
Phase:
PHASE4
Brief Summary
Erectile dysfunction (ED) is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. An ideal treatment option should be effective and reliable, hav...
Eligibility Criteria
Inclusion
- Men \>/= 18 years of age,
- ED 6 months or longer
- Stable sexual relationship for \> 6 month.
Exclusion
- Primary hypoactive sexual desire
- History of myocardial infarction, stroke or life-threatening arrhythmia within prior 6 month
- Nitrate therapy
- Other exclusion criteria apply according to the Summary of Product Characteristics
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2003
Estimated Enrollment :
333 Patients enrolled
Trial Details
Trial ID
NCT00681772
Start Date
March 1 2003
End Date
November 1 2003
Last Update
December 11 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.